Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer

[1] Adelstein DJ(2000)Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy J Clin Oncol 18 2032-2039

[2] Rice TW(2008)Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 1435-1442

[3] Rybicki LA(2001)Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophagal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone Cancer 91 2165-2174

[4] Larto MA(2005)A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 1140-1146

[5] Ciezki J(2003)Outcomes after esophagectomy: a ten-year prospective cohort Ann Thorac Surg 75 217-222

[6] Saxton J(2007)Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 1160-1168

[7] DeCamp M(1999)Oxaliplatin: in vitro evidence of its radiation sensitizing activity: pre-clinical observations relevant to clinical trials. Abstract 202 Int J Radiat Oncol Biol Phys 45 253-254

[8] Vargo JJ(1997)Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216-1220

[9] Dumot JA(2002)Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3–T4 unresectable rectal cancer: a phase II IATTGI study Int J Radiat Oncol Biol Phys 54 397-402

[10] Zuccaro G(2007)Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer Br J Cancer 96 432-438

[1] Adelstein DJ(2000)Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy J Clin Oncol 18 2032-2039

[2] Rice TW(2008)Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 1435-1442

[3] Rybicki LA(2001)Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophagal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone Cancer 91 2165-2174

[4] Larto MA(2005)A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 1140-1146

[5] Ciezki J(2003)Outcomes after esophagectomy: a ten-year prospective cohort Ann Thorac Surg 75 217-222

[6] Saxton J(2007)Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 1160-1168

[7] DeCamp M(1999)Oxaliplatin: in vitro evidence of its radiation sensitizing activity: pre-clinical observations relevant to clinical trials. Abstract 202 Int J Radiat Oncol Biol Phys 45 253-254

[8] Vargo JJ(1997)Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216-1220

[9] Dumot JA(2002)Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3–T4 unresectable rectal cancer: a phase II IATTGI study Int J Radiat Oncol Biol Phys 54 397-402

[10] Zuccaro G(2007)Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer Br J Cancer 96 432-438